Literature DB >> 16825393

Rapid genotypic detection of rifampin- and isoniazid-resistant Mycobacterium tuberculosis directly in clinical specimens.

Didi Bang1, Ase Bengård Andersen, Vibeke Østergaard Thomsen.   

Abstract

A multiplex PCR DNA strip assay (Genotype MTBDR) designed to detect rifampin (rpoB) and high-level isoniazid (katG) resistance mutations in Mycobacterium tuberculosis isolates was optimized for clinical specimens. Successful genotypic results were achieved with 36 of 38 (95%) smear-positive respiratory specimens, allowing rapid therapeutic adjustments in transmittable drug-resistant tuberculosis.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16825393      PMCID： PMC1489488          DOI： 10.1128/JCM.00752-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  20 in total

Review 1.  Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update.

Authors:  S Ramaswamy; J M Musser
Journal:  Tuber Lung Dis       Date:  1998

2.  Evaluation of a new commercial assay for diagnosis of pulmonary and nonpulmonary tuberculosis.

Authors:  I S Johansen; V Ø Thomsen; A Johansen; P Andersen; B Lundgren
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2002-06-14       Impact factor: 3.267

3.  Detection of rifampin resistance in Mycobacterium tuberculosis in a single tube with molecular beacons.

Authors:  H H El-Hajj; S A Marras; S Tyagi; F R Kramer; D Alland
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

4.  Rifampicin and isoniazid resistance mutations in Mycobacterium tuberculosis strains isolated from patients in Kazakhstan.

Authors:  D Hillemann; T Kubica; R Agzamova; B Venera; S Rüsch-Gerdes; S Niemann
Journal:  Int J Tuberc Lung Dis       Date:  2005-10       Impact factor: 2.373

5.  Detection and drug-susceptibility testing of M. tuberculosis from sputum samples using luciferase reporter phage: comparison with the Mycobacteria Growth Indicator Tube (MGIT) system.

Authors:  Svetoslav Bardarov; Horng Dou; Katherine Eisenach; Niaz Banaiee; S u Ya; John Chan; William R Jacobs; Paul F Riska
Journal:  Diagn Microbiol Infect Dis       Date:  2003-01       Impact factor: 2.803

6.  Direct detection of rifampin- and isoniazid-resistant Mycobacterium tuberculosis in auramine-rhodamine-positive sputum specimens by real-time PCR.

Authors:  Maite Ruiz; Maria J Torres; Ana C Llanos; Aurelio Arroyo; Jose C Palomares; Javier Aznar
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

7.  Rapid detection of rifampicin susceptibility of Mycobacterium tuberculosis in sputum specimens by mycobacteriophage assay.

Authors:  T Butt; R N Ahmad; R K Afzal; A Mahmood; M Anwar
Journal:  J Pak Med Assoc       Date:  2004-07       Impact factor: 0.781

8.  Simple, phage-based (FASTPplaque) technology to determine rifampicin resistance of Mycobacterium tuberculosis directly from sputum.

Authors:  H Albert; A Trollip; T Seaman; R J Mole
Journal:  Int J Tuberc Lung Dis       Date:  2004-09       Impact factor: 2.373

Review 9.  The global situation of MDR-TB.

Authors:  Marcos A Espinal
Journal:  Tuberculosis (Edinb)       Date:  2003       Impact factor: 3.131

10.  Rapid differentiation between clinically relevant mycobacteria in microscopy positive clinical specimens and mycobacterial isolates by line probe assay.

Authors:  Isik Somuncu Johansen; Bettina H Lundgren; Jacob Pontoppidan Thyssen; Vibeke Østergaard Thomsen
Journal:  Diagn Microbiol Infect Dis       Date:  2002-08       Impact factor: 2.803
View more
  22 in total

1.  Detection of resistance to second-line antituberculosis drugs by use of the genotype MTBDRsl assay: a multicenter evaluation and feasibility study.

Authors:  Olga Ignatyeva; Irina Kontsevaya; Alexander Kovalyov; Yanina Balabanova; Vladislav Nikolayevskyy; Kadri Toit; Anda Dragan; Daniela Maxim; Svetlana Mironova; Tiina Kummik; Ionela Muntean; Ekaterina Koshkarova; Francis Drobniewski
Journal:  J Clin Microbiol       Date:  2012-02-29       Impact factor: 5.948

2.  Newly developed primers for comprehensive amplification of the rpoB gene and detection of rifampin resistance in Mycobacterium tuberculosis.

Authors:  Leen Rigouts; Oscar Nolasco; Pim de Rijk; Elie Nduwamahoro; Armand Van Deun; Andy Ramsay; Jorge Arevalo; Françoise Portaels
Journal:  J Clin Microbiol       Date:  2006-11-08       Impact factor: 5.948

3.  Sequence analyses of just four genes to detect extensively drug-resistant Mycobacterium tuberculosis strains in multidrug-resistant tuberculosis patients undergoing treatment.

Authors:  Silke Feuerriegel; Helen S Cox; Nana Zarkua; Hamraev A Karimovich; Kai Braker; Sabine Rüsch-Gerdes; Stefan Niemann
Journal:  Antimicrob Agents Chemother       Date:  2009-05-26       Impact factor: 5.191

4.  Evaluation of methods for rapid detection of resistance to isoniazid and rifampin in Mycobacterium tuberculosis isolates collected in the Caribbean.

Authors:  Patrick Eberechi Akpaka; Shirematee Baboolal; Denise Clarke; Lorraine Francis; Nalin Rastogi
Journal:  J Clin Microbiol       Date:  2008-08-13       Impact factor: 5.948

5.  Multicenter evaluation of Bactec MGIT 960 system for second-line drug susceptibility testing of Mycobacterium tuberculosis complex.

Authors:  S-Y Grace Lin; Edward Desmond; Donald Bonato; Wendy Gross; Salman Siddiqi
Journal:  J Clin Microbiol       Date:  2009-09-09       Impact factor: 5.948

6.  Evaluation of two molecular assays for rapid detection of mycobacterium tuberculosis resistance to fluoroquinolones in high-tuberculosis and -multidrug-resistance Settings.

Authors:  I Kontsevaya; S Mironova; V Nikolayevskyy; Y Balabanova; S Mitchell; F Drobniewski
Journal:  J Clin Microbiol       Date:  2011-06-01       Impact factor: 5.948

Review 7.  General and advanced diagnostic tools to detect Mycobacterium tuberculosis and their drug susceptibility: a review.

Authors:  Md A Gazi; Md R Islam; Mohammad G Kibria; Z Mahmud
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-01-06       Impact factor: 3.267

8.  Frequency of mutations in rifampicin and isoniazid resistant isolates of M. tuberculosis: an analysis from Central India.

Authors:  Prabha Desikan; Atul Kharate; Nikita Panwalkar; Jyoti Khurana; Shaina Beg Mirza; Aparna Chaturvedi; Reeta Varathe; Manju Chourey; Pradeep Kumar; Nitin Doshi; Manoj Pandey
Journal:  Germs       Date:  2016-12-02

9.  Direct comparison of the genotype MTBC and genomic deletion assays in terms of ability to distinguish between members of the Mycobacterium tuberculosis complex in clinical isolates and in clinical specimens.

Authors:  Akos Somoskovi; Jillian Dormandy; Jeremy Rivenburg; Maria Pedrosa; Melinda McBride; Max Salfinger
Journal:  J Clin Microbiol       Date:  2008-03-19       Impact factor: 5.948

10.  GenoType MTBDRplus assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical samples.

Authors:  A Lacoma; N Garcia-Sierra; C Prat; J Ruiz-Manzano; L Haba; S Rosés; J Maldonado; J Domínguez
Journal:  J Clin Microbiol       Date:  2008-09-10       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.